Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.20.1
Significant Accounting Policies (Tables)
3 Months Ended
Apr. 30, 2020
Accounting Policies [Abstract]  
Summary of Cash, Cash Equivalents, and Restricted Cash

The following table provides a summary of cash, cash equivalents and restricted cash that constitutes the total amounts shown in the consolidated statements of cash flows as of April 30, 2020 and 2019:

 

 

 

As of April 30,

 

 

 

2020

 

 

2019

 

 

 

(Amounts in thousands)

 

Cash and cash equivalents

 

$

6,187

 

 

$

14,697

 

Restricted cash

 

 

200

 

 

 

 

Total cash, cash equivalents and restricted cash

 

$

6,387

 

 

$

14,697

 

Schedule of Anti-dilutive Securities Excluded from Computation of Loss Per Share

The number of common shares used in the computation of diluted net loss per share for the periods presented does not include the effect of the following potentially outstanding common shares because the effect would have been anti-dilutive:

 

 

 

For the Three Months

Ended April 30,

 

 

 

2020

 

 

2019

 

 

 

(Amounts in thousands)

 

Stock options

 

 

766

 

 

 

2,937

 

Restricted stock units

 

 

58

 

 

 

291

 

Deferred stock units

 

 

81

 

 

 

188

 

Performance stock units

 

 

 

 

 

115

 

 

 

 

905

 

 

 

3,531